表 1.

经AuGC/ZIF-8富集后HRP酶解物中糖肽的详细信息

No.	Mr(m/z)	Glycan composition	Peptide sequence
H1	1842.841	[Xyl]1[Hex]3 [Fuc]1[HexNAc]2	NVGLN#R
H2	2073.113	[Xyl]1[Hex]3 [Fuc]1[HexNAc]2	PN#VSNIVR
H3	2273.156	[Xyl]1[Hex]2 [Fuc]1[HexNAc]2	SILLDN#TTSFR
H4	2322.100	[Hex]2 [HexNAc]2	MGN#ITPLTGTQGQIR
H5	2541.128	[Xyl]1[Hex]3[Fuc]1[HexNAc]2	SSPN#ATDTIPLVR
H6	2611.216	[Xyl]1[Hex]3[HexNAc]2	MGN#ITPLTGTQGQIR
H7	2850.382	[Fuc]1[HexNAc]1	GLIQSDQELFSSPN#ATDTIPLVR
H8	3073.335	[Fuc]1[HexNAc]1	LHFHDCFVNGCDASILLDN#TTSFR
H9	3088.337	[Xyl]1[Hex]3[Fuc]1[HexNAc] 2	GLCPLNGN#LSALVDFDLR
H10	3321.343	[Xyl]1[Hex]3[Fuc]1[HexNAc]2	QLTPTFYDNSCPN#VSNIVR
H11	3354.298	[Xyl]1[Hex]3[Fuc]1[HexNAc]2	SFAN#STQTFFNAFVEAMDR
H12	3372.248	[Xyl]1[Hex]3[Fuc]1[HexNAc]2	SFAN#STQTFFNAFVEAM*DR
H13	3537.497	[Hex]3[Fuc]1[HexNAc]2	GLIQSDQELFSSPN#ATDTIPLVR
H14	3605.486	[Xyl]1[Hex]3[Fuc]1[HexNAc]2	NQCRGLCPLNGN#LSALVDFDLR
H15	3671.579	[Xyl]1[Hex]3[Fuc]1[HexNAc]2	GLIQSDQELFSSPN#ATDTIPLVR
H16	3894.496	[Xyl]1[Hex]3[Fuc]1[HexNAc]2	LHFHDCFVNGCDASILLDN#TTSFR
H17	4056.530	[Xyl]1[Hex]3[HexNAc]2	QLTPTFYDNSC(AAVESACPR)PN#VSNIVR-H2O
H18	4221.659	[Xyl]1[Hex]3[Fuc]1[HexNAc]2	QLTPTFYDNSC(AAVESACPR)PN#VSNIVR
H19	4982.884	[Xyl]1[Hex]3[Fuc]1[HexNAc]2 or	LYN#FSNTGLPDPTLN#TTYLQTLR
		[Xyl]1[Hex]3[Fuc]1[HexNAc]2

N#: N-linked glycosylation site.